-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Although acute basilar artery occlusion (ABAO) is an uncommon ischemic stroke , it accounts for only a small percentage (about 1%) of all ischemic strokes , and accounts for 5% to 10% of strokes caused by large vessel occlusion.
Although acute basilar artery occlusion (ABAO) is an uncommon ischemic stroke , it accounts for only a small percentage (about 1%) of all ischemic strokes , and accounts for 5% to 10% of strokes caused by large vessel occlusion.
For ABAO patients with severe symptoms (ie NIHSS ≥ 21 points), the related benefits of EVT are still uncertain
JAMA
This prospective, nationwide cohort study was conducted using data from BASILAR in China
Among 542 patients with ABAO and severe symptoms (median [IQR] age, 65[57-74] years; 147[27.
Compared with SMT, EVT and mRS scores improved (OR=3.
90-day mRS score
In patients receiving EVT, the baseline NIHSS score increased and the probability of good functional outcome decreased (for every 1 point increase in the score, OR=.
In patients receiving EVT, the baseline NIHSS score increased and the probability of good functional outcome decreased (for every 1 point increase in the score, OR=.
This study found that in patients with ABAO and severe symptoms, EVT is associated with an increased chance of a functional outcome
references:
Outcomes of Endovascular Therapy in Acute Basilar Artery Occlusion With Severe Symptoms.
Outcomes of Endovascular Therapy in Acute Basilar Artery Occlusion With Severe Symptoms.
Leave a message here
